Rankings
▼
Calendar
AUPH Q2 2023 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
AUPH
Aurinia Pharmaceuticals Inc.
$2B
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$41M
+47.2% YoY
Gross Profit
$40M
96.2% margin
Operating Income
-$16M
-39.0% margin
Net Income
-$11M
-27.7% margin
EPS (Diluted)
$-0.08
QoQ Revenue Growth
+20.6%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$12M
Balance Sheet
Total Assets
$549M
Total Liabilities
$157M
Stockholders' Equity
$392M
Cash & Equivalents
$82M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$41M
$28M
+47.2%
Gross Profit
$40M
$27M
+50.2%
Operating Income
-$16M
-$36M
+55.1%
Net Income
-$11M
-$36M
+67.6%
Revenue Segments
Product
$41M
99%
License, Royalty and Collaboration Revenue
$394,000
1%
← FY 2023
All Quarters
Q3 2023 →